IHS Chemical Week

World News and Views :: Top of the News

Sanofi-Aventis to Acquire Genzyme for $20.1 Billion

11:57 PM MST | February 16, 2011 | Deepti Ramesh

Sanofi-Aventis says it has entered into a definitive agreement with biotechnology company Genzyme (Cambridge, MA), under which Sanofi-Aventis will acquire Genzyme for $74/share in cash, or about $20.1 billion. The transaction, which has been approved by the boards of directors of both companies, is expected to close early in the second quarter of 2011. The combination will enhance Sanofi-Aventis’ growth strategy by expanding its footprint in biotechnology, Sanofi-Aventis says. Genzyme, since 1981, has grown from a small start-up to a diversified enterprise...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa